Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQ-A3334 + NAs in Chronic HBV Infection
NCT06706310Phase 2Active, not recruiting
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tq-a3334 in Chronic Hepatitis B (CHB), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Dec 2024; status: active, not recruiting.
02
Drugs
tq-a3334
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT06706310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06706310.